SKYEY - SkyePharma PLC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SKYEY - SkyePharma PLC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (32)	8/1/1999 6:30:00 PM
From: Dave K	of 56

SmithKline to buy into SkyePharma -- paper Sunday August 1, 12:58 pm Eastern Time LONDON, Aug 1 (Reuters) - Anglo-U.S. drug company SmithKline Beecham Plc is close to taking a $10 million stake in British biotechnology company SkyePharma Plc (quote from Yahoo! UK & Ireland: SKP.L), the Sunday Telegraph reported. The paper said the investment was part of a deal under which SkyePharma would reformulate SmithKline's Requip treatment for Parkinson's disease. A spokesman for SmithKline said he had no knowledge of such a deal, and declined further comment. SkyePharma already has links with SmithKline, and in February announced U.S. Food and Drug Administration approval for a controlled release version of SmithKline's anti-depressant Paxil/Seroxat.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next